Vaxcell-Bio Therapeutics Inc. (323990)
Market Closed
15 Oct, 06:30 AM
KRX SM KRX SM Primary ₩
3,890. 00
-140
-3.4739%
₩
241.01B Market Cap
- P/E Ratio
- Div Yield
79,828 Volume
- Eps
₩ 4,030
Previous Close Want to track 323990 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vaxcell-Bio Therapeutics Inc. (323990) Statistics
Valuation metrics
Market Cap 241.01B
Enterprise value 96.67B
Trailing P/E (ttm) -6.76
Forward P/E -
PEG ratio 0.36
Price/Sales (ttm) 15.46
Price/Book (mrq) 1.89
Enterprise Value/Revenue 14.85
Enterprise Value/EBITDA -7.15
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 69.48K
Average volume (90 days) 135.85K
Price summary
52-Week low 3,350
52-Week high 11,520
Beta -
50-Day moving average 4,333.12
200-Day moving average 5,384.51
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:1
Last split Date 10 Nov 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.29%
Operating margin -2.58%
Operational effectiveness
Return on assets -0.25%
Return on equity -0.25%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 280.97
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -643.73
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 640.41
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 5.56%
Book value per share (mrq) 2,298.92
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
